Hydroxyapatite compound: Indication, Dosage, Side Effect, Precaution

Concise Prescribing Info Full Prescribing Info

Dosage/Direction for Use Contraindications Special Precautions Adverse Reactions Drug Interactions Action CIMS Class

Concise Prescribing Info

Indications/Uses

Prevention of postmenopausal osteoporosis.

Dosage/Direction for Use

Adult: PO As ossein-hydroxyapatite compd: 1,660 mg twice daily.

Contraindications

Hypersensitivity. Children <6 yr. Prolonged immobilization accompanied by hypercalciuria.

Special Precautions

Monitor serum calcium level during treatment. To be taken with vitamin D for maximal benefit. Caution when used in renally impaired patients.

Adverse Reactions

Risk of hypercalciuria.

Drug Interactions

Biphosphonates may increase the osteoconductive and regenerative properties of hydroxyapatite when used together.

CIMS Class

Agents Affecting Bone Metabolism

Disclaimer: This information is independently developed by CIMS based on hydroxyapatite compound from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com